The effects of maternal cigarette smoke exposure on somatic mutant frequencies at the hprt locus in healthy newborns

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 377, Issue 1, 1997, Pages 115-123

  Finette, B A ^a   Poseno, T ^a   Vacek, P M ^a   Albertini, R J ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Cotinine; Genetic monitoring; Hprt; Newborns; Smoking; T cell cloning assay

Indexed keywords

CIGARETTE SMOKE; COTININE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE;

ARTICLE; CLONING; CONTROLLED STUDY; FEMALE; FETUS; GENOTOXICITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONITORING; MUTATION RATE; NEWBORN; PASSIVE SMOKING; PRENATAL EXPOSURE; PRIORITY JOURNAL; SMOKING; SOMATIC MUTATION; T LYMPHOCYTE;

CLONE CELLS; COTININE; FEMALE; FETAL BLOOD; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INFANT, NEWBORN; MALE; MOTHERS; MUTATION; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SMOKING; T-LYMPHOCYTES; TOBACCO SMOKE POLLUTION;

NICOTIANA TABACUM;

EID: 0030908438     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(97)00069-9     Document Type: Article

References (29)

1. Byrd R.S., Howard C.R. Children's passive and prenatal exposure to cigarette smoke. Pediatr. Ann. 24:(12):1995;640-645.
2. Ahlsten G., Ewald U., Tuvemo T. Prostacyclin-like activity in umbilical arteries is dose-dependently reduced by maternal smoking and related to nicotine levels. Biol. Neonate. 58:1990;271-278.
3. Oryszczyn M.-P., Godin J., Annesi I., Hellier G., Kauffmann F. In utero exposure to parental smoking, cotinine measurements, and cord blood IgE. J. Allergy Clin. Immunol. 87:(6):1991;1169-1174.
4. Streissguth, A.P., P.D. Sampson, H.M. Barr, F.L. Bookstein and H.C. Olson (1994) The effects of prenatal exposure to alcohol and tobacco: Contributions from the Seattle longitudinal prospective study and implications for public policy, in: H.L. Needleman and D. Bellinger (Eds.), Prenatal Exposure to Toxicants: Developmental Consequences, The Johns Hopkins University Press, Baltimore, pp. 148-183.
5. Olds D.L., Henderson C.R., Tatelbaum R.R. Intellectual impairment in children who smoke cigarettes during pregnancy. Pediatrics. 93:(2):1994;221-227.
6. Martinez F.D., Wright A.L., Taussig L.M., Associates T.G.H.M. The effect of paternal smoking on the birthweight of newborns whose mothers did not smoke. Am. J. Public Health. 84:(9):1994;1489-1491.
7. Martin T.R., Bracken M.B. Association of low birth weight with passive smoke exposure in pregnancy. Am. J. Epidemiol. 124:(4):1986;633-642.
8. Floyd R.L., Zahniser C., Gunter E.P., Kendrick J.S. Smoking during pregnancy: prevelance, effects, and intervention. Birth. 18:(1):1991;48-53.
9. Denissenko M., Pao A., Tang M.-S., Pfeifer G.P. Preferential formation of Benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science. 274:1996;430-432.
10. Little J., Vainio H. Mutagenic lifestyles? A review of evidence off associations between germ-cell mutations in humans and smoking, alcohol consumption and use of 'recreational' drugs. Mutation Res. 313:1994;131-151.
11. Pasanen M., Pelkonen O. Xenobiotic and steroid-metabolizing monooxygenases catalysed by cytochrome P450 and glutatione S-transferase conjugation in the human placenta and their relationships to maternal cigarette smoking. Placenta. 11:1990;75-85.
12. Robinson D., Goodall K., Albertini R.J., O'Neill J.P., Finette B.A., Sala-Trepat M., Tates A.D., Beare D., Green M.H.L., Cole J. An analysis of in vivo hprt mutant frequency in circulating T-lymphocytes in the normal human poulation: a comparison of four databases. Mutation Res. 313:1994;227-247.
13. Albertini, R.J. and R.B. Hayes (1996) in: P. Toniolo et al. (Eds.) Applications of Biomarkers to Cancer Epidemiology, Vol. 142, IARC: World Health Organization, in press.
14. Ammenheuser M.M., Berenson A.B., Stiglich N.J., Whorton E.B., Ward J.B. A dose-related increase in the frequency of hprt mutant lymphocytes in smoking mothers and their newborns. Abstr. Environ. Mol. Mutagen. 21:(22):1993;2.
15. McGinniss M.J., Falta M.T., Sullivan L.S., Albertini R.J. In vivo hprt mutant frequencies in T-cells of normal human newborns. Mutation Res. 240:1990;117-126.
16. Manchester D.K., Nicklass J.A., O'Neill J.P., Lippert M.J., Grant S.G., Richard L., Moore I.D.H., Jensen R.H., Albertini R.J., Bigbee W.L. Sensitivity of somatic mutations in human umbilical cord blood to maternal environments. Environ. Mol. Mutagen. 26:1995;203-212.
17. O'Neill J.P., McGinniss M.J., Berman J.K., Sullivan L.M., Nicklas J.A., Albertini R.J. Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans. Mutagenesis. 00:1987;87-92.
18. Finette B.A., Sullivan L.M., O'Neil J.P., Nicklas J.A., Vacek P.M., Albertini R.J. Determination of somatic mutant frequencies at the hprt locus in T-lymphocytes from a healthy pediatric population: Statistical comparison between fetal, children and adult mutant frequencies, cloning efficiency and age. Mutation Res. 308:1994;223-231.
19. Henderson L., Cole J., Cole H., James S.E., Green M. Detection of somatic mutations in man: evaluation of the microtiter cloning assay for T-lymphocytes. Mutagenesis. 1:1986;195-200.
20. Tates A.D., van Dam F.J., van Mossel H., Schoemaker H., Thijssen J.C.P., Woldring V.M., Zwinderman A.H., Natarajan A.T. Use of the clonal assay for the measurement of frequencies of hprt mutants in T-lymphocytes from five control populations. Mutation Res. 253:1991;199-213.
21. Van Vunakis, H., H.B. Gjika and J.J. Langone (1987) in: I.K. O'Neill et al. (Eds.), Environmental Carcinogens: Methods of Analysis and Exposure Measurement, W.H.O. International Agency for Research on Cancer, Lyon, pp. 317-330.
22. Bulay O.M., Wattenberg L.W. Carcinogenic effects of subcutaneous administration of benzo(a)pyrene during pregnancy on the progeny. Proc. Soc. Biol. Med. 135:1970;84-86.
23. 3 descendants of pregnant mice injected with 7,12-dimethlybenz(a)anthracene. Int. J. Cancer. 4:1969;219-225.
24. Meberg A., Sande H., Foss O.P., Stenwig J.T. Smoking during pregnancy - effects on the fetus and on thiocyanate levels in mothers and baby. Acta Paediatr. Scand. 68:1979;547-552.
25. Bureau M.A., Monette J., Shapcott D., Mathieu J.-L., Lippe J., Blovin D., Berthiaume Y., Begin R. Carboxyhemoglobin concentration in fetal cord blood and in the blood of mothers who smoked during labor. Pediatrics. 69:(3):1982;371-373.
26. Pershagen G., Ericson A., Otterblad-Olausson P. Maternal smoking in pregnancy: does it increase the risk of childhood cancer. Int. J. Epidemiol. 21:(1):1992;1-5.
27. Green M.H.L., O'Neill J.P., Cole J. Suggestions concerning the relationship between mutant frequency and mutation rate at the hprt locus in human peripheral T-lymphocytes. Mutation Res. 334:1995;323-339.
28. Albertini R.J., Sullivan L.M., Berman J.K., Greene C.J., Stewart J.A., Silveira J.M., O'Neill J.P. Mutagenicity monitoring in humans by autoradiographic assay for mutant T-lymphocytes. Mutation Res. 204:(3):1988;481-492.
29. Pluth J.M., Janice N., O'Neill J.P., Albertini R.J. Increased frequency of specific genomic deletions resulting from in vitro malathion exposure. Cancer Res. 56:1996;2393-2399.